Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells

Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1

(2013) Nicole A de Weerd et al.   NATURE IMMUNOLOGY

Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties

(2013) Michele Caraglia et al.   PROTEIN AND PEPTIDE LETTERS

The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells

(2012) Maria Cristina De Martino et al.   ENDOCRINE-RELATED CANCER

Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma

(2012) Jan Schmidt et al.   JOURNAL OF CLINICAL ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Type I interferons as radiosensitisers for pancreatic cancer

(2011) Marjolein J.M. Morak et al.   EUROPEAN JOURNAL OF CANCER

Beta-interferon for multiple sclerosis

(2011) Richard A. Rudick et al.   EXPERIMENTAL CELL RESEARCH

A Novel PEGylated Interferon Beta-1a for Multiple Sclerosis: Safety, Pharmacology, and Biology

(2011) Xiao Hu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Interferon: Current Status and Future Prospects in Cancer Therapy

(2011) Ben X. Wang et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031

(2010) V. J. Picozzi et al.   ANNALS OF ONCOLOGY

Adjuvant Therapy in Pancreatic Cancer

(2010) Amy Thomas et al.   DIGESTIVE DISEASES

Response of pancreatic cancer cells treated with interferon-α or β and co-exposed to ionising radiation

(2010) Eva Jöst et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

The Expression of Interferon Receptor α/β in Human Pancreatic Cancer in Nude Mice is Essential for Tumor Response to Interferon α Treatment

(2010) Reza F. Saidi et al.   JOURNAL OF SURGICAL RESEARCH

Phenotype and Genotype of Pancreatic Cancer Cell Lines

(2010) Emily L. Deer et al.   PANCREAS

Adjuvant Interferon-based Chemoradiation Followed By Gemcitabine for Resected Pancreatic Adenocarcinoma: A Single-Institution Phase II Study

(2009) David C. Linehan et al.   ANNALS OF SURGERY

Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways

(2009) M. Caraglia et al.   CURRENT CANCER DRUG TARGETS